SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

SVB Leerink Maintains Outperform on Globus Medical, Lowers Price Target to $56

SVB Leerink maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $63 to $56.

Benzinga · 05/08/2020 10:29

SVB Leerink maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $63 to $56.